{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:20:16Z","timestamp":1793733616977,"version":"4.6.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["BES-2015-072204"],"award-info":[{"award-number":["BES-2015-072204"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR20\/00015"],"award-info":[{"award-number":["JR20\/00015"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["GCB14142170MONT"],"award-info":[{"award-number":["GCB14142170MONT"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["INVES19045ROME"],"award-info":[{"award-number":["INVES19045ROME"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2022 FI_B1 00085M"],"award-info":[{"award-number":["2022 FI_B1 00085M"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.xcrm.2023.101006","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T10:41:50Z","timestamp":1681209710000},"page":"101006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["MYC activation impairs cell-intrinsic IFN\u03b3 signaling and confers resistance to anti-PD1\/PD-L1 therapy in lung cancer"],"prefix":"10.1016","volume":"4","author":[{"given":"Juan J.","family":"Alburquerque-Bejar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Navajas-Chocarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Saigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ferrero-Andres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Morillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vilarrubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Mate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Munoz-Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio A.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Blecua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Davalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Pros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Llabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Torres-Diz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Esteve-Codina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-5627","authenticated-orcid":false,"given":"Montse","family":"Sanchez-Cespedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101006_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101006_bib2","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1158\/1078-0432.CCR-18-0267","article-title":"MET -oncogenic and JAK2 -inactivating alterations are independent factors that affect regulation of PD-L1 expression in lung cancer","volume":"24","author":"Saigi","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101006_bib3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101006_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(19)30801-0","volume":"21","author":"Garassino","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2023.101006_bib5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.annonc.2021.06.004","article-title":"Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer","volume":"32","author":"Sugawara","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2023.101006_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2023.101006_bib7","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1\u2013positive non\u2013small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.101006_bib8","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1158\/1078-0432.CCR-16-1946","article-title":"Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition","volume":"23","author":"Pereira","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101006_bib9","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1038\/s41388-019-0855-x","article-title":"Determinants of immunological evasion and immunocheckpoint inhibition response in non-small cell lung cancer: the genetic front","volume":"38","author":"Saigi","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2023.101006_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-\u03b3 pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101006_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2023.101006_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.101006_bib13","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2023.101006_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101006_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.annonc.2019.09.001","article-title":"Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors","volume":"31","author":"Pros","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2023.101006_bib50","article-title":"Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity","volume":"7","author":"Li","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101006_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.101006_bib17","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/humu.23302","article-title":"IFN-\u03b3R1 defects: mutation update and description of the IFNGR1 variation database: van de VOSSE and van DISSEL","volume":"38","author":"van de Vosse","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.xcrm.2023.101006_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8657","article-title":"cGAS in action: expanding roles in immunity and inflammation","volume":"363","author":"Ablasser","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101006_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101006_bib23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101006_bib51","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1038\/s41467-021-24618-3","article-title":"SMARCA4 deficient tumours are vulnerable to KDM6A\/UTX and KDM6B\/JMJD3 blockade","volume":"12","author":"Romero","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101006_bib52","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/15592294.2018.1469891","article-title":"JQ1 affects BRD2-dependent and independent transcription regulation without disrupting H4-hyperacetylated chromatin states","volume":"13","author":"Handoko","year":"2018","journal-title":"Epigenetics"},{"key":"10.1016\/j.xcrm.2023.101006_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101006_bib54","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1101\/gad.314815.118","article-title":"POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer","volume":"32","author":"Huang","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2023.101006_bib20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.161.5.1135","article-title":"Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer","volume":"161","author":"Doyle","year":"1985","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2023.101006_bib21","first-page":"186","article-title":"Paucity of beta 2-microglobulin expression on small cell lung cancer, bronchial carcinoids and certain other neuroendocrine tumors","volume":"55","author":"Funa","year":"1986","journal-title":"Lab. Invest."},{"key":"10.1016\/j.xcrm.2023.101006_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm3890","article-title":"Histone core modifications regulating nucleosome structure and dynamics","volume":"15","author":"Tessarz","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2023.101006_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","article-title":"An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer","volume":"36","author":"Burr","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101006_bib25","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1158\/2159-8290.CD-20-0913","article-title":"Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity","volume":"11","author":"Mahadevan","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101006_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0092-8674(89)90107-4","article-title":"Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes","volume":"58","author":"Harada","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101006_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/humu.20730","article-title":"Frequent BRG1\/SMARCA4-inactivating mutations in human lung cancer cell lines","volume":"29","author":"Medina","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.xcrm.2023.101006_bib28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/2159-8290.CD-13-0799","article-title":"MAX inactivation in small cell lung cancer disrupts MYC\u2013SWI\/SNF programs and is synthetic lethal with BRG1","volume":"4","author":"Romero","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101006_bib29","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1128\/MCB.22.18.6471-6479.2002","article-title":"Maximal induction of a subset of interferon target genes requires the chromatin-remodeling activity of the BAF complex","volume":"22","author":"Liu","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2023.101006_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2023.101006_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024824118","article-title":"MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex","volume":"118","author":"Llabata","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101006_bib32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2213-2600(18)30284-4","article-title":"Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis","volume":"6","author":"Duruisseaux","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.xcrm.2023.101006_bib33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101006_bib34","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nbt.3344","article-title":"Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes","volume":"33","author":"Shukla","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2023.101006_bib35","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101006_bib36","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1038\/s41467-021-24164-y","article-title":"Notch signaling and efficacy of PD-1\/PD-L1 blockade in relapsed small cell lung cancer","volume":"12","author":"Roper","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101006_bib37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jtho.2020.11.006","article-title":"YAP1 expression in SCLC defines a distinct subtype with T-cell\u2013inflamed phenotype","volume":"16","author":"Owonikoko","year":"2021","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.xcrm.2023.101006_bib38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.20151764","article-title":"The macrophage IRF8\/IRF1 regulome is required for protection against infections and is associated with chronic inflammation","volume":"213","author":"Langlais","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2023.101006_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"HOW cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.xcrm.2023.101006_bib40","first-page":"1969","article-title":"Deregulated c-myc expression overrides IFN gamma-induced macrophage growth arrest","volume":"10","author":"Vairo","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2023.101006_bib41","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1158\/2159-8290.CD-19-0620","article-title":"Repression of the type I interferon pathway underlies MYC- and KRAS-dependent evasion of NK and B cells in pancreatic ductal adenocarcinoma","volume":"10","author":"Muthalagu","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101006_bib42","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41467-020-16447-7","article-title":"MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies","volume":"11","author":"Swaminathan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101006_bib43","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.cell.2017.11.013","article-title":"Myc cooperates with ras by programming inflammation and immune suppression","volume":"171","author":"Kortlever","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101006_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8780","article-title":"Therapeutic KRAS G12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers","volume":"8","author":"Mugarza","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2023.101006_bib45","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2017.10.022","article-title":"Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung cancer","volume":"171","author":"Topper","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101006_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ccr.2009.12.043","article-title":"Tumor stroma-derived TGF-\u03b2 limits myc-driven lymphomagenesis via suv39h1-dependent senescence","volume":"17","author":"Reimann","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101006_bib47","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.immuni.2018.09.020","article-title":"The lineage-defining transcription factors SOX2 and NKX2-1 determine lung cancer cell fate and shape the tumor immune microenvironment","volume":"49","author":"Mollaoglu","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.101006_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","article-title":"MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate","volume":"38","author":"Ireland","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101006_bib49","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1038\/s41467-022-31238-y","article-title":"Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101006_bib56","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101006_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.101006_bib58","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2023.101006_bib59","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2023.101006_bib60","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101006_bib61","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2023.101006_bib62","author":"Andrews"},{"key":"10.1016\/j.xcrm.2023.101006_bib63","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2105-15-182","article-title":"Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads","volume":"15","author":"Jiang","year":"2014","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2023.101006_bib64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2023.101006_bib65","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2023.101006_bib66","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2023.101006_bib67","doi-asserted-by":"crossref","first-page":"W160","DOI":"10.1093\/nar\/gkw257","article-title":"deepTools2: a next generation web server for deep-sequencing data analysis","volume":"44","author":"Ram\u00edrez","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101006_bib68","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/bioinformatics\/btr189","article-title":"MEME-ChIP: motif analysis of large DNA datasets","volume":"27","author":"Machanick","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.101006_bib55","doi-asserted-by":"crossref","first-page":"51621","DOI":"10.18632\/oncotarget.18255","article-title":"Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer","volume":"8","author":"P\u00e9rez-Salvia","year":"2017","journal-title":"Oncotarget"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:54:56Z","timestamp":1762988096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2666379123001167"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101006","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MYC activation impairs cell-intrinsic IFN\u03b3 signaling and confers resistance to anti-PD1\/PD-L1 therapy in lung cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101006"}}